Monoclonal antibodies to respiratory syncytial virus and uses therefor
US7867497B2 · kind B2 · utility
15Cited by
12References
22Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Sep 23, 2008 |
| Grant date | Jan 11, 2011 |
| Priority date | — |
| Expiry date | Dec 28, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/76
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to particular human monoclonal antibodies and fragments thereof that find use in the detection, prevention and treatment of respiratory syncytial virus infections. In particular, these antibodies may neutralize RSV. Also disclosed are improved methods for producing monoclonal antibodies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.